Evidence map›Paper›PMID 32973170›Full record

ArticleMolecular psychiatry2021

Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder.

Deepak Cyril D'Souza, Rajiv Radhakrishnan, Mika Naganawa, Suhas Ganesh, Nabeel Nabulsi, Soheila Najafzadeh, Jim Ropchan, Mohini Ranganathan, Jose Cortes-Briones, Yiyun Huang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Assessment of noninvasive quantification of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Article
  8. Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [Neurology(R) neuroimmunology & neuroinflammation · 2025
    Article
  9. Article
  10. Review
  11. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  12. Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  13. Exploring causal mechanisms of psychosis risk.Neuroscience and biobehavioral reviews · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. First-in-Human Study ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  18. Article
  19. Review
  20. First-in-Human PET Imaging of [Molecular imaging · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Deepak Cyril D'Souza *Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Deepak.dsouza@yale.edu.ORCID http://orcid.org/0000-0003-3141-1462
Rajiv Radhakrishnan *Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Mika NaganawaDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-4408-2621
Suhas GaneshDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1833-1986
Nabeel NabulsiDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-8129-0051
Soheila NajafzadehDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.
Jim RopchanDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.
Mohini RanganathanDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Jose Cortes-BrionesDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Yiyun HuangDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.
Richard E CarsonDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-9338-7966
Patrick SkosnikDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Yale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis is one of the most commonly and widely used psychoactive drugs. The rates of cannabis misuse have been increasing. Therefore, understanding the effects of cannabis use on the brain is important. Adolescent and adult rodents exposed to repeated administration of cannabinoids show persistent microstructural changes in the hippocampus both pre- and post-synaptically. Whether similar alterations exist in human cannabis users, has not yet been demonstrated in vivo. Positron emission tomography (PET) and [

Indexed as

Marijuana AbuseAnimalsBrainHippocampusNerve Tissue ProteinsPositron-Emission TomographyPyridinesNerve Tissue ProteinsPyridines

Identifiers

PMID32973170
OpenAlexW3088452468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.